133 related articles for article (PubMed ID: 11728679)
21. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
22. The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies.
Körholz D; Claviez A; Hasenclever D; Kluge R; Hirsch W; Kamprad F; Dörffel W; Wickmann L; Papsdorf K; Dieckmann K; Kahn T; Mauz-Körholz C; Dannenberg C; Pötter R; Brosteanu O; Schellong G; Sabri O
Klin Padiatr; 2004; 216(3):150-6. PubMed ID: 15175959
[TBL] [Abstract][Full Text] [Related]
23. [Can children with Hodgkin's disease be treated with chemotherapy only?].
Balwierz W; Klekawka T; Moryl-Bujakowska A; Matysiak M; Sopyło B; Wachowiak J; Kaczmarek-Kanold M; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Mitura-Lesiuk M; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Krawczuk-Rybak M; Muszyńska-Rosłan K; Młynarski W; Stolarska M; Sobol G; Wieczorek M; Karolczyk G; Urbanek-Dadela A
Przegl Lek; 2010; 67(6):375-81. PubMed ID: 21344765
[TBL] [Abstract][Full Text] [Related]
24. Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy.
Zubizarreta PA; Alfaro E; Guitter M; Sanchez La Rosa C; Galluzzo ML; Millán N; Fiandrino F; Felice MS
J Pediatr Hematol Oncol; 2017 Nov; 39(8):602-608. PubMed ID: 28902084
[TBL] [Abstract][Full Text] [Related]
25. Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy.
Karmiris TD; Grigoriou E; Tsantekidou M; Spanou E; Mihalakeas H; Baltadakis J; Apostolidis J; Pagoni M; Karakasis D; Bakiri M; Mitsouli C; Harhalakis N; Nikiforakis E
Leuk Lymphoma; 2003 Sep; 44(9):1523-8. PubMed ID: 14565654
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.
Thomas J; Fermé C; Noordijk EM; Morschhauser F; Girinsky T; Gaillard I; Lugtenburg PJ; André M; Lybeert MLM; Stamatoullas A; Beijert M; Hélias P; Eghbali H; Gabarre J; van der Maazen RWM; Jaubert J; Bouabdallah K; Boulat O; Roesink JM; Christian B; Ong F; Bordessoule D; Tertian G; Gonzalez H; Vranovsky A; Quittet P; Tirelli U; de Jong D; Audouin J; Aleman BMP; Henry-Amar M
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1133-1145. PubMed ID: 29229324
[TBL] [Abstract][Full Text] [Related]
27. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
[TBL] [Abstract][Full Text] [Related]
28. EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease.
Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kontopidou FN; Boussiotis VA; Papavassiliou C; Kittas C; Pangalis GA
Leuk Lymphoma; 2000 Mar; 37(1-2):131-43. PubMed ID: 10721777
[TBL] [Abstract][Full Text] [Related]
29. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
[TBL] [Abstract][Full Text] [Related]
30. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
[TBL] [Abstract][Full Text] [Related]
31. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
[TBL] [Abstract][Full Text] [Related]
32. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
[TBL] [Abstract][Full Text] [Related]
33. Pediatric stage IV Hodgkin disease. Long-term survival.
Bader SB; Weinstein H; Mauch P; Silver B; Tarbell NJ
Cancer; 1993 Jul; 72(1):249-55. PubMed ID: 7685242
[TBL] [Abstract][Full Text] [Related]
34. Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.
Landman-Parker J; Pacquement H; Leblanc T; Habrand JL; Terrier-Lacombe MJ; Bertrand Y; Perel Y; Robert A; Coze C; Thuret I; Donadieu J; Schaison G; Leverger G; Lemerle J; Oberlin O
J Clin Oncol; 2000 Apr; 18(7):1500-7. PubMed ID: 10735898
[TBL] [Abstract][Full Text] [Related]
35. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
36. [Treatment regimen for children and adolescents with Hodgkin's disease designed to decrease late complications of radiotherapy].
Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Rokicka-Milewska R; Sopylo B; Kolakowska-Mrozowska B; Chybicka A; Boguslawska-Jaworska J; Pisarek J; Ras M; Sonta-Jakimczyk D; Janik-Moszant A; Kolecki P; Kaczmarek-Kanold M; Kowalczyk J; Odoj T; Matysiak M; Newecka-Samol T; Balcerska A; Adamkiewicz-Drozynska E; Wysocki M; Kurylak A
Med Wieku Rozwoj; 2001; 5(3 Suppl 1):25-35. PubMed ID: 12004149
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
38. The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control.
Mendenhall NP; Rodrigue LL; Moore-Higgs GJ; Marcus RB; Million RR
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):551-61. PubMed ID: 10348284
[TBL] [Abstract][Full Text] [Related]
39. The benefit of consolidation radiotherapy to initial disease bulk in patients with advanced Hodgkin's disease who achieved complete remission after standard chemotherapy.
Bayoumi Y; Al-Homaidi A; Zaidi S; Tailor I; Motiabi I; Alshehri N; Al-Ghazali A; Almudaibigh S
J Blood Med; 2015; 6():87-92. PubMed ID: 25848329
[TBL] [Abstract][Full Text] [Related]
40. Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone.
Dühmke E; Franklin J; Pfreundschuh M; Sehlen S; Willich N; Rühl U; Müller RP; Lukas P; Atzinger A; Paulus U; Lathan B; Rüffer U; Sieber M; Wolf J; Engert A; Georgii A; Staar S; Herrmann R; Beykirch M; Kirchner H; Emminger A; Greil R; Fritsch E; Koch P; Drochtert A; Brosteanu O; Hasenclever D; Loeffler M; Diehl V
J Clin Oncol; 2001 Jun; 19(11):2905-14. PubMed ID: 11387364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
